These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1448851)

  • 41. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of Serum-Free and Cerebrospinal Fluid Valproic Acid Levels in Patients With Hypoalbuminemia After Craniotomy.
    Li Z; Gao W; Liu G; Chen W
    Ther Drug Monit; 2020 Aug; 42(4):610-616. PubMed ID: 32106182
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Total and free valproic acid: plasma level/dose ratio in monotherapy.
    Abadín JA; Durán JA; Sánchez A; Serrano JS
    Methods Find Exp Clin Pharmacol; 1991 Apr; 13(3):221-5. PubMed ID: 2051846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder.
    Vasudev K; Goswami U; Kohli K
    Psychopharmacology (Berl); 2000 May; 150(1):15-23. PubMed ID: 10867972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid.
    Iinuma K; Hayasaka K; Narisawa K; Tada K; Hori K
    Eur J Pediatr; 1988 Dec; 148(3):267-9. PubMed ID: 3145882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Importance of Monitoring Unbound Valproic Acid Concentration in Patients with Hypoalbuminemia.
    Doré M; San Juan AE; Frenette AJ; Williamson D
    Pharmacotherapy; 2017 Aug; 37(8):900-907. PubMed ID: 28574586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in unbound and total valproic acid concentrations after replacement of carbamazepine with oxcarbazepine.
    Battino D; Croci D; Granata T; Bernardi G; Monza G
    Ther Drug Monit; 1992 Oct; 14(5):376-9. PubMed ID: 1448844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
    Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J
    Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Valproic acid dosages necessary to maintain therapeutic concentrations in children.
    Suzuki Y; Cox S; Hayes J; Walson PD
    Ther Drug Monit; 1991 Jul; 13(4):314-7. PubMed ID: 1780963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
    Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH
    Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary metabolites of valproic acid in epileptic patients.
    Katayama H; Watanabe M; Yoshitomi H; Yoshida H; Kimoto H; Kamiya A; Hayashi T; Akimura T
    Biol Pharm Bull; 1998 Mar; 21(3):304-7. PubMed ID: 9556166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy.
    Kim SH; Chung HR; Kim SH; Kim H; Lim BC; Chae JH; Kim KJ; Hwang YS; Hwang H
    Neuropediatrics; 2012 Jun; 43(3):135-9. PubMed ID: 22618302
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and pharmacokinetic observations on sodium valproate - a 5-year follow-up study in 100 children with epilepsy.
    Henriksen O; Johannessen SI
    Acta Neurol Scand; 1982 May; 65(5):504-23. PubMed ID: 6810648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of valproic acid treatment on body composition, leptin and the soluble leptin receptor in epileptic children.
    Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Karall D; Schoenherr E; Tatarczyk T; Engl J; Laimer M; Luef G; Ebenbichler CF
    Epilepsy Res; 2008 Aug; 80(2-3):142-9. PubMed ID: 18472247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Developing pharmacokinetics-pharmacodynamics model of valproic acid syrup based on prediction of population pharmacokinetics parameter and seizure frequency in Indonesian pediatric epilepsy outpatients.
    Prawira Nata Nugraha IK; Purnamayanti A; Ngurah Made Suwarba IG; Parfati N
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):305-311. PubMed ID: 34214324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Seven cases of decreased serum valproic acid concentration during concomitant use of carbapenem antibiotics].
    Lee SG; Kim JH; Joo JY; Kwon OH
    Korean J Lab Med; 2007 Oct; 27(5):338-43. PubMed ID: 18094598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of genetic variants in six candidate genes with valproic acid therapy optimization.
    Hung CC; Ho JL; Chang WL; Tai JJ; Hsieh TJ; Hsieh YW; Liou HH
    Pharmacogenomics; 2011 Aug; 12(8):1107-17. PubMed ID: 21806385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy.
    Luef G; Abraham I; Hoppichler F; Trinka E; Unterberger I; Bauer G; Lechleitner M
    Metabolism; 2002 Oct; 51(10):1274-8. PubMed ID: 12370846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.